The Capitol Forum also reports the FDA is looking at an interim pathway to allow compounding of unapproved wellness peptides before a final rule.
Recap by typeshit. Full story at The Capitol Forum.
HHS is proposing temporary enforcement priorities and side effect reporting for compounded peptides, with more specifics in Becker's rundown.
Bloomberg reports the Kennedy plan to widen peptide access comes with a side effect reporting rule for compounding pharmacies.
A Facebook user explains that compounded GLP-1 versions were allowed during the branded drug shortage and flags what that means for people still using them.
Sahpra reports about 600 fake medicine complaints this year, and new compounding rules aren't due until early next year, which industry head Stavros Nicolaou calls too late.
UTHealth Houston researchers found 11% lower odds of major heart complications, but the real gap works out to about one fewer event per 1,000 patients.
Many online GLP-1 prescriptions are filled by compounding pharmacies. USA TODAY walks through how to verify the one filling yours.
Loading…